title: Reversibility of the monocrotaline pulmonary hypertension rat model.
authors.forename: Gerrina
authors.initials: G
authors.lastname: Ruiter
authors.forename: Frances S
authors.initials: FS
authors.lastname: de Man
authors.forename: Ingrid
authors.initials: I
authors.lastname: Schalij
authors.forename: Shellice
authors.initials: S
authors.lastname: Sairras
authors.forename: Katrien
authors.initials: K
authors.lastname: Grünberg
authors.forename: Nico
authors.initials: N
authors.lastname: Westerhof
authors.forename: Willem J
authors.initials: WJ
authors.lastname: van der Laarse
authors.forename: Anton
authors.initials: A
authors.lastname: Vonk-Noordegraaf
mesh_terms: D000818:Animals; D001160:Arterioles / Q000187:drug effects; D004195:Disease Models, Animal; D018450:Disease Progression; D004334:Drug Administration Schedule; D004452:Echocardiography; D006439:Hemodynamics; D006976:Hypertension, Pulmonary / Q000139:chemically induced / Q000503:physiopathology* / Q000628:therapy*; D008099:Liver / Q000187:drug effects; D008297:Male; D016686:Monocrotaline / Q000009:adverse effects*; D011651:Pulmonary Artery / Q000187:drug effects; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar
chemical_list: D016686:Monocrotaline